#10

The Carlat Psychiatry Report

Drug Interactions That Matter

Jason Mallo, DO
New data on which psychiatric drug interactions have real clinical impact—and which ones you can stop worrying about. Read Full Article

#9

The Carlat Hospital Psychiatry Report

Medical Conditions That Mimic Psychiatric Illnesses

Manjit K. Bhandal, MD, and Michael Donath, MD

This review covers six medical conditions—acute intermittent porphyria, anti-NMDA receptor encephalitis, lupus, Lyme disease, neuroendocrine tumors, and syphilis—that can masquerade as psychiatric disorders. Read Full Article

#8

The Carlat Psychiatry Report

Akathisia: Manifestations and Treatment

Michael Poyurovsky, MD
Dr. Poyurovsky offers practical guidance for identifying and treating akathisia, a movement disorder marked by inner restlessness Read Full Article

#7

The Carlat Hospital Psychiatry Report

Akathisia: Manifestations and Treatment

Michael Poyurovsky, MD
Dr. Poyurovsky offers practical guidance for identifying and treating akathisia, a movement disorder marked by inner restlessness Read Full Article

#6

The Carlat Psychiatry Report

ECT: An Update 

W. Vaughn McCall, MD, MS
The FDA has changed the labeling on ECT, and Vaughn McCall clarifies where this treatment fits among newer interventions like ketamine and TMS. Read Full Article

#5

The Carlat Psychiatry Report

How to Diagnose Borderline Personality Disorder

C. Jason Mallo, DO
We show you how to ask about borderline criteria and how to convey the diagnosis to the patient. Read Full Article

#4

The Carlat Psychiatry Report

How to Select a Stimulant for Adult ADHD

Gregory Malzberg, MD
We have 30 stimulant formulations, but do all deserve prizes? We find a few with niche advantages, and three that rise to the to. Read Full Article

#3

The Carlat Psychiatry Report

Lithium Orotate

By Chris Aiken, MD
It's gaining popularity as a "natural" form of lithium, but this over-the-counter form has hidden risks.
Read Full Article

#2

The Carlat Psychiatry Report

ADHD: Beyond Stimulants

With Nicholas J. Nissen, MD
Stimulants may hold the prize for effect size in ADHD, but nonstimulants have advantages for the right patient.
Read Full Article

#1

The Carlat Psychiatry Report

New Weight Loss Drugs in Psychiatry

By Chris Aiken, MD and David Liebers, MD
From liraglutide (Saxenda) to tirzepatide (Mounjaro), new weight loss medications are reshaping the treatment of diabetes and obesity. But what's their impact in psychiatry? Read Full Article